Press releases by Abzu.
News about Abzu, from Abzu. Read the latest press releases on changes in our company and our innovative work in RNA Tx.
Christian Lund joins Abzu’s board of directors.
October 10, 2023
Christian Lund, co-founder of Templafy, joins the board of directors at Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies.
Abzu welcomes Kasper Sommer as its new CFO.
October 4, 2023
Abzu, the Danish/Spanish startup that builds trustworthy AI to tackle complex challenges for the world's leading companies., welcomes Kasper Sommer as its new Chief Financial Officer.
Abzu earns ISO 27001:2022 certification: Elevating trust with ISO-certified AI.
October 3, 2023
Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies, secures ISO 27001:2022 certification, reinforcing its value proposition for explainable, resilient, and safe AI solutions.
Abzu’s explainable AI used in NASA GeneLab study to explain skin disorders in space.
September 12, 2023
Scientists at Abzu and NASA GeneLab have identified gene combinations that explain the origin of rashes astronauts develop during space missions
Abzu wins Best HealthTech at the 2023 Nordic Startup Awards.
May 24, 2023
Abzu, the Danish / Spanish startup that has introduced new methods and technology to drive discoveries and reduce R&D costs for pharmaceutical and biotech companies, is thrilled to win Best HealthTech at the 2023 Nordic Startup Awards.
Abzu and Contera Pharma expand strategic partnership to add target identification to RNA therapeutic design platform.
March 22, 2023
The application designs RNA therapeutics through parallel hypotheses testing of drug targets and individual antisense oligonucleotide (ASO) drug properties.
Subscribe for
notifications from Abzu.
You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.
